Research view
Switch to patient viewALS (motor neurone disease): who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target to see only the groups that work on it.
- All targets
- TDP-43 8
- SOD1 8
- C9orf72 4
- NRF2 0
- STING 0
- SIRT1 0
- HDAC 0
- NLRP3 0
- TREM2 0
- BDNF 0
- MAPK 0
- APOE 0
- GLP-1 0
- HMGB1 0
- mTOR 0
- SMN1 0
- TP53 0
- AMPK 0
- BTK 1
- CXCR4 0
- HSP90 1
- JAK 0
- JNK 0
- LAG-3 0
- NMDA 0
- PI3K 0
- PINK1 0
- PPAR 0
- TFEB 0
- TNF 0
- AKT 0
- APP 0
- ATM 0
- AXL 0
- BCL-2 0
- CDK4/6 0
- COX-2 0
- CSF1R 0
- ERK 0
- GPX4 0
- IL-1 0
- MAPT 0
- PARP 0
- PCSK9 0
- PDE4 1
- PSEN1 0
- PTEN 0
- SNCA 0
- STK11 0
- TLR4 0
- TTR 0
- VEGF 0
- YAP 0
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-SE
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
European Commission (Horizon Europe) · HORIZON-ERC
Engineered Humanized Spinal Cord Construct for Advancing Health and Disease Research (SpineCraft)
The disease is named only in the funder's project summary, not in the title.
5 of 14 running projects, newest first. Listed amounts together: €25.3m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 7
- Organoids 7
- Mendelian Randomization Analysis 18
- CRISPR-Cas Systems 8
- Gene Expression Profiling 23
- Sequence Analysis, RNA 2
- Whole Genome Sequencing 6
- Exome Sequencing 6
- Proteomics 29
- Metabolomics 7
- Mass Spectrometry 6
- Flow Cytometry 2
- Immunohistochemistry 5
- Liquid Biopsy 2
- Positron-Emission Tomography 14
- Magnetic Resonance Imaging 57
- Machine Learning 18
- Deep Learning 7
- Cohort Studies 80
- Genome-Wide Association Study 24
Optimized gGBE enables robust G-to-Y conversion in mammalian cells and zebrafish embryos.
CRISPR/Cas9-based nanodelivery systems for precision gene editing in neuroinflammation.
Embedded CRISPRi Enhances Gene-Silencing Efficiency in Drosophila.
Versatile CRISPR-Cas Tools for Gene Regulation in Zebrafish via an Enhanced Q Binary System.
Development of a targeted BioPROTAC degrader selective for misfolded SOD1.
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.